136 related articles for article (PubMed ID: 31745028)
1. Predominance of high-risk human papillomavirus genotype 16 and 39 in women with premalignant and malignant cervical pathology from Raipur, Chhattisgarh: Clinical evaluation of tagging oligonucleotide cleavage and extension mediated genotyping assay.
Negi SS; Bhargava A; Singh P; Aggarwal S; Hussain N; Das P
Indian J Med Microbiol; 2019; 37(2):255-262. PubMed ID: 31745028
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
3. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
[No Abstract] [Full Text] [Related]
7. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
9. [Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].
Liu M; Wang CX; Deng XM; Wang LS; Zhang J; Li W; Zheng GX; Wang JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):487-90. PubMed ID: 17877181
[TBL] [Abstract][Full Text] [Related]
10. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
12. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
13. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
Schiffman M; Burk RD; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Aldrich C; Tam T; Erlich H; Apple R; Befano B; Castle PE
J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
[TBL] [Abstract][Full Text] [Related]
14. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.
Li M; Du X; Lu M; Zhang W; Sun Z; Li L; Ye M; Fan W; Jiang S; Liu A; Wang M; Meng Y; Li Y
J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807
[TBL] [Abstract][Full Text] [Related]
15. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
16. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.
Gage JC; Schiffman M; Solomon D; Wheeler CM; Gravitt PE; Castle PE; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1095-101. PubMed ID: 23603204
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
18. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
19. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
20. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
